3WJ – targeting ligand-antiMIR21
Purpose:This nanoparticle can be used for specific delivery of anti-microRNA21 to cells in vitro and in vivo.
Get Quote| Product Name | Catalog number | Synthesis scale | |
|---|---|---|---|
|
Triple Negative Breast Cancer (TNBC)
|
3WJ – RFA (TNBC)-antiMIR21 | RNP-M21-01-1 |
1 nmol
|
| RNP-M21-01-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with an aptamer targeting Triple Negative Breast Cancer (TNBC) cells and antiMIR21] |
|||
| 3WJ – RFM-antiMIR21 | RNP-M21-07-1 | 1 nmol | |
| RNP-M21-07-2 | 50 nmol | ||
|
[Description: Serum stable 3WJ RNA nanoparticle with a mutant aptamer (serving as a targeting control) and antiMIR21] |
|||
| 3WJ – RFA(TNBC)-Scr | RNP-MSc-01-1 |
1 nmol
|
|
| RNP-MSc-01-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with an aptamer targeting Triple Negative Breast Cancer (TNBC) cells and scramble miRNA ] |
|||
|
HER2+
Cancer
|
3WJ – RFA (HER2)-antiMIR21 | RNP-M21-03-1 |
1 nmol
|
| RNP-M21-03-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with an aptamer targeting HER2 + cancer cells and antiMIR21] |
|||
| 3WJ – RFM-antiMIR21 | RNP-M21-07-1 | 1 nmol | |
| RNP-M21-07-2 | 50 nmol | ||
|
[Description: Serum stable 3WJ RNA nanoparticle with a mutant RNA aptamer (serving asa targeting control) and antiMIR21] |
|||
| 3WJ – RFA(HER2)-Scr | RNP-MSc-03-1 |
1 nmol
|
|
| RNP-MSc-03-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with an aptamer targeting HER2 + cancer cells and scramble miRNA ] |
|||
|
Folate Receptor+ Cancer
|
3WJ – RFC (FA)-antiMIR21 | RNP-M21-05-1 |
1 nmol
|
| RNP-M21-05-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with a folate ligand for targeting folate receptor (+) cells and antiMIR21] |
|||
| 3WJ – RF-antiMIR21 | RNP-M19-08-1 | 1 nmol | |
| RNP-M19-08-2 | 50 nmol | ||
|
[Description: Serum stable 3WJ RNA nanoparticle without ligand (serving as vector control) but with antiMIR21] |
|||
| 3WJ – RFC(FA)-Scr | RNP-MSc-05-1 |
1 nmol
|
|
| RNP-MSc-05-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with a folate ligand for targeting folate receptor (+) cells and scramble miRNA] |
|||
|
Epithelial
Cancer
|
3WJ – RFA (EC)-antiMR21 | RNP-M21-04-1 |
1 nmol
|
| RNP-M21-04-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with an aptamer targeting Epithelial Cancer (EC) cells and antiMIR21] |
|||
| 3WJ – RFM-antiMIR21 | RNP-M19-07-1 | 1 nmol | |
| RNP-M19-07-2 | 50 nmol | ||
|
[Description: Serum stable 3WJ RNA nanoparticle with a mutant aptamer (serving as a targeting control) and antiMIR21] |
|||
| 3WJ – RFA(EC)-Scr | RNP-MSc-04-1 |
1 nmol
|
|
| RNP-MSc-04-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with an aptamer targeting Epithelial Cancer (EC) cells and scramble miRNA] |
|||
|
Galactose Receptor+
Cancer
|
3WJ – RFC (GL)-antiMIR21 | RNP-M21-06-1 |
1 nmol
|
| RNP-M21-06-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with a galactose ligand for targeting liver cancer cells and antiMIR21] |
|||
| 3WJ – RF-antiMIR21 | RNP-M21-08-1 | 1 nmol | |
| RNP-M21-08-2 | 50 nmol | ||
|
Description: Serum stable 3WJ RNA nanoparticle without ligand (serving as vector control) but with antiMIR21] |
|||
| 3WJ – RFC(GL)-Scr | RNP-MSc-06-1 |
1 nmol
|
|
| RNP-MSc-06-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with a galactose ligand for targeting liver cancer cells and scramble miRNA] |
|||
|
PSMA+
Cancer
|
3WJ – RFA (PC)-antiMR21 | RNP-M21-02-1 |
1 nmol
|
| RNP-M21-02-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with an aptamer targeting Prostate Cancer (PC) cells and antiMIR21] |
|||
| 3WJ – RFM-antiMIR21 | RNP-M19-07-1 | 1 nmol | |
| RNP-M19-07-2 | 50 nmol | ||
|
[Description: Serum stable 3WJ RNA nanoparticle with a mutant aptamer (serving as a targeting control) and antiMIR21] |
|||
| 3WJ – RFA(PC)-Scr | RNP-MSc-02-1 |
1 nmol
|
|
| RNP-MSc-02-2 |
50 nmol
|
||
|
[Description: Serum stable 3WJ RNA nanoparticle with an aptamer targeting Prostate Cancer (PC) cells and scramble miRNA] |
|||
